22 Jul SkylarkBio
Posted at 20:34h
in
Jodi Cook, Ph.D., CEO and President
Oct. 9 | 11:15am | FLW Ballroom F
Cambridge, MA
(Private)
Skylark Bio is a gene therapy Company working on targeted micro-dose delivery of gene therapies initially focused on addressing pediatric hearing loss, but with the potential to rapidly progress into other rare diseases. Genetic hearing loss is a devastating disorder that is diagnosed at birth and can impede the development of basic communication and learning skills that can have life-long consequences. Through proprietary gene therapy solutions, the company has a mission to create a world where anyone anywhere can experience life in its sensory dimensions.
